|
KMID : 1141720190070020065
|
|
폐쇄성폐질환
2019 Volume.7 No. 2 p.65 ~ p.74
|
|
|
Optimal Management of Mild Asthma
|
|
Lee Tae-Hoon
|
|
|
Abstract
|
|
|
|
Mild asthma is defined as asthma controlled by the treatment of GINA steps 1 and 2, but in fact, 80% of mild asthmatics are not controlled and 10% experience exacerbation at least once a year. These uncontrol/exacerbation in mild asthma could be overcome through anti-inflammatory maintenance treatment, however, many mild asthma patients do not want maintenance therapy. This incompliance has a variety of reasons for each patient, such as a lack of understanding of the disease (asthma is a disease that requires treatment for inflammation), cost or adverse drug reaction issues, it is also taught by doctors (asthma paradox: patients’ preference for "as needed treatment"). Recently, the effectiveness of anti-inflammatory reliever (without anti-inflammatory maintenance) has been demonstrated as a new treatment option for mild asthma: asthma exacerbation rate was similar with anti-inflammatory maintenance group, asthma control was also better than as needed SABA group (without anti-inflammatory maintenance). In particular, this method is expected to be a practical solution for patients with poor compliance.
|
|
|
KEYWORD
|
|
|
Mild asthma, Incompliance, Paradox, Anti-inflammatory reliever
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|